Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
25,178
Frequently Asked Questions
What is market cap of Alcon Inc. - Registered Shares?
The market cap of Alcon Inc. - Registered Shares is $33.19B
What is the 52 week high for Alcon Inc. - Registered Shares?
The 52 week high for Alcon Inc. - Registered Shares is $81.98.
What is the 52 week low for Alcon Inc. - Registered Shares?
The 52 week low for Alcon Inc. - Registered Shares is $55.21.
What is Alcon Inc. - Registered Shares stock price today?
Alcon Inc. - Registered Shares' stock price today is $67.49.
What is the pe ratio of Alcon Inc. - Registered Shares?
The PE ratio of Alcon Inc. - Registered Shares is 98.97.
What is the price to book ratio of Alcon Inc. - Registered Shares?
The price to book ratio of Alcon Inc. - Registered Shares is 1.6868.
What is Alcon Inc. - Registered Shares's EBITDA?
Alcon Inc. - Registered Shares's EBITDA is 2245.
What is the 50-day moving average of Alcon Inc. - Registered Shares?
The 50-day moving average of Alcon Inc. - Registered Shares is 71.4108.
How many employess does Alcon Inc. - Registered Shares has?
Alcon Inc. - Registered Shares has 25178 employees.